MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)
$2.88 -0.012 (-0.4149%)
Analysed MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) News Sources
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation
15-04-2026
yahoo.com
February 2026's TSX Penny Stocks To Consider
13-02-2026
yahoo.com
TSX Opportunities GoldMining And 2 Other Promising Penny Stocks
13-02-2026
yahoo.com
TSX Penny Stocks Under CA$300M Market Cap: 3 Promising Picks
12-02-2026
yahoo.com
Medexus Pharmaceuticals Inc (MEDXF) Q3 2026 Earnings Call Highlights: Strong Graphopex Demand ...
12-02-2026
yahoo.com
Medexus Pharmaceuticals Q3 Earnings Call Highlights
12-02-2026
marketbeat.com
Almadex Minerals And 2 Other TSX Penny Stocks To Watch
12-02-2026
yahoo.com
Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
11-02-2026
yahoo.com
TSX Penny Stocks To Watch In February 2026
11-02-2026
yahoo.com
3 TSX Penny Stocks With Market Caps Over CA$70M
10-02-2026
yahoo.com
What is the current price of MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)?
The current price of MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) is $2.88.
MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) since the previous trading day is $-0.012.
MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) since the previous trading day is -0.4149%.
What is the most recent average sentiment score for MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)?
The most recent average sentiment score for MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) is 87 out of 100.
What is the most recent average sentiment for MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)?
The most recent sentiment for MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS) is .
SEC-8K** Filing Available For MEDEXUS PHARMACEUTICALS INC (MEDXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.